Navigation Links
Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
Date:11/24/2011

THE HAGUE, November 24, 2011 /PRNewswire/ --

ProQares - a leading provider of testing, evaluation and certification services for protective equipment against chemical hazards - announced today a partnership with U.S.-based Rapid Pathogen Screening, Inc. (RPS®) - a leading developer of point-of-care diagnostic tests, to deploy the RPS chemical nerve agent detector in numerous countries throughout the European and Asia Pacific regions.  

The RPS chemical nerve agent detector is the first-of-its-kind point-of-care diagnostic test for human exposure to chemical poisons in the blood, including Soman, Sarin, Tabun, and VX, and is capable of detecting low-level chemical nerve agent exposure in 10 minutes or less with only a simple finger-stick blood sample.

"The partnership with RPS complements ProQares' mission to contribute to the protection of humans against toxic threats by providing fast and reliable test results," said Jack van Hoof, Managing Director of ProQares. "Through the partnership, ProQares will support RPS in marketing the RPS chemical nerve agent detector to its worldwide network of government and industrial organizations."

"This partnership will accelerate the deployment of this break-through technology and ensure that governments and other organizations charged with protecting the public from a chemical weapons attack have the most sophisticated tools available," said Robert Van Dine, Chief IP and Government Affairs Officer for RPS.

In June, in his address to the NATO Conference on WMD Arms Control, Disarmament and Non-Proliferation, Ambassador Ahmet Uzümcü, director-general of the Organisation for the Prohibition of Chemical Weapons (OPCW), focused NATO on his concern that "the future use of chemical weapons in a conventional military sense is remote. The misuse, on the other hand, of toxic chemicals, especially in an asymmetric sense, appears to be the more likely scenario."

A single chemical attack in an urban commercial or residential setting can result in tens of thouy" timex="11/24/2011 2:37:52 AM" dirsub="(sands of people that require immediate d...)" id="22399" index="medicine" dir="Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally" dir2="Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Inter..." keywords1=",medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medical technology" keywords="Leading,Chemical,Weapons,Preparedness,Companies,Announce,Partnership,to,Deploy,Break-through,Diagnostic,Test,Internationally" description="sands of people that require immediate diagnosis and treatment. Treatm...In early 2012 RPS expects to apply the CE mark to the RPS chemical nerve agent detector and begin d... ..." url=u&"/medicine-technology-1/Leading-Chemical-Weapons-Preparedness-Companies-Announce-Partnership-to-Deploy-Break-through-Diagnostic-Test-Internationally-22399-2/" title="Leading%20Chemical%20Weapons%20Preparedness%20Companies%20Announce%20Partnership%20to%20Deploy%20Break-through%20Diagnostic%20Test%20Internationally" %> Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Inter... ( THE HAGUE November 24 2011 /- Pro...)

Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
Date:11/24/2011

sands of people that require immediate diagnosis and treatment. Treatment for chemical weapon nerve agent exposure often is most effective within the first 40 minutes. The RPS chemical nerve agent detector responds to this need by providing a rapid, accurate and cost-effective diagnosis at the point-of-care.

In early 2012, RPS expects to apply the CE mark to the RPS chemical nerve agent detector and begin discussions with the U.S. Food and Drug Administration to bring it to market in the United States. The product is not currently CE-marked and is not yet available for sale in the United States.


'/>"/>
SOURCE ProQares
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
2. Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
3. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
4. Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020
5. Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
6. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
7. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
8. American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville
9. Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search
10. Phreesia Continues to Enhance its Market-Leading Eligibility and Benefits Verification Process for Medical Practices
11. CADCA and Leading Makers of OTC Medicines Call Communities to Action During National Medicine Abuse Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... SAN DIEGO , June 23, 2016 /PRNewswire/ ... advancing programs that address medical conditions resulting from ... that it has appointed Greg Doyle ... member of Leading BioSciences, executive management team and ... officer and chief financial officer. He will provide ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):